Urban Indians are Suffering from Brittle Bones : Study

admin
admin
· 3 min read
Urban Indians are suffering from Brittle Bones : Study

• According to a study by Department of Orthopaedics, Indraprastha Apollo Hospital, New Delhi with the help of city-based non-government organization “Arthritis Care Foundation,’ about 9 % suffering from osteoporosis and 60 % suffering from osteopenia.

Report of the study has been published in latest March (2018) edition of Indian Journal of Medical Research (IJMR), published by Indian Council of Medical Research (ICMR)

A study on osteoporotic fracture risk in urban Indian population shows that the incidence of osteoporosis was high in the city dwellers. According to the study among people aged between 38 and 68 years shows 9% of them, including men and women, suffer from osteoporosis while nearly 60% have osteopenia.

Osteopenia and osteoporosis are related bone diseases. Osteoporosis causes bones to become weak and brittle- so brittle that a fall or even mild stresses such as bending over or coughing can cause a fracture. Osteoporosis-related fractures most commonly occur in the hip, wrist or spine. Osteoporosis is usually considered a ‘silent disease’ until a fracture occurs. Osteoporosis leads to nearly nine million fractures annually worldwide. Osteopenia is a bone condition characterized by bone loss that is not as severe as in osteoporosis.

According to the report of the study, published in latest March (2018) edition of  Indian Journal of Medical Research (IJMR), published by Indian Council of Medical Research (ICMR), this survey was done among people living in living in areas like Sukhdev Vihar, Sarita Vihar, Kalkaji, East of Kailash and Mayur Vihar in New Delhi. This survey was carried out by Dr. Vipul Vijay, Dr. Amit K. Agarwal & Dr. Prashant Maheshwari under the guidance of Dr. (Prof.) Raju Vaishya.

“In our study, the presence of osteopenia and osteoporosis was found to be higher in the urban Indian population. A high incidence of osteopenia and osteoporosis was observed in the studied population. Significant association of sex, parent history of fracture and secondary osteoporosis was found in the present study whereas alcohol and steroid intake were not found to be significantly associated with the low T-scores”, said Dr. Raju Vaishya, senior orthopedic surgeon at Indraprastha Apollo Hospital, New Delhi.

He said that low level of bone density could have a serious socio-economic burden in the future as the population of the elderly are bound to increase. Identification of individuals who are at risk of developing osteoporosis and adequate treatment can prevent long-term morbidity due to osteoporotic fractures. Unfortunately, the most population is largely unaware of the serious complications associated with osteoporosis. Even in the absence of a large-scale cross-sectional study, hip fractures (HFs) are considered common and the peak incidence of osteoporotic HF is at a younger age, around 50-60 yr.

For this study, 14 camps were organized in total and every third person attending the camp was included in the study. The cluster of individuals mainly belonged to the middle and upper class, according to revised modified BG Prasad classification15. The number of patients included in the study from each camp ranged from 20 to 35.

Link to the study report in IJMR: Click here

Read Next

India successfully validates the first indigenous HPV test for Cervical Cancer screening
News
June 13, 2026

India successfully validates the first indigenous HPV test for Cervical Cancer screening

India has achieved a significant milestone in cervical cancer prevention with the successful validation of the country’s first indigenous HPV DNA tests, which meet international standards for cervical cancer screening. Published in the International Journal of Cancer, a multicentre study involving leading Indian and international institutions found that Molbio Diagnostics Truenat HPV-HR Plus met the […]
Article by: IMT News Desk
Glenmark Launches Winlevi® in Key European Markets for the Treatment of Acne Vulgaris
News
June 12, 2026

Glenmark Launches Winlevi® in Key European Markets for the Treatment of Acne Vulgaris

Glenmark Specialty S.A. (GSSA), a wholly owned subsidiary of Glenmark Pharmaceuticals Ltd., has announced the launch of Winlevi® (clascoterone 10 mg/g cream) across key markets in Europe. This follows the grant of marketing authorization of the product for the treatment of acne vulgaris in both adults and adolescents aged 12 to <18 years (with usage in […]
Article by: IMT News Desk
Thyrocare Expands Its Presence in Prayagraj with the Launch of Its New Diagnostic Laboratory
News
June 12, 2026

Thyrocare Expands Its Presence in Prayagraj with the Launch of Its New Diagnostic Laboratory

Thyrocare Technologies Limited has announced the set-up of its new diagnostic laboratory in Prayagraj, Uttar Pradesh, in association with SecondMedic. The new laboratory is equipped with advanced testing infrastructure and supported by trained professionals, enabling timely and error-free diagnostic results. It caters to both specialised and routine testing requirements, offering support to ongoing and preventive […]
Article by: IMT News Desk
AstraZeneca Gets CDSCO Approval for Trastuzumab Deruxtecan in HER2-Positive Breast Cancer
News
June 12, 2026

AstraZeneca Gets CDSCO Approval for Trastuzumab Deruxtecan in HER2-Positive Breast Cancer

AstraZeneca Pharma India Ltd. (AZPIL) announced that the Central Drugs Standard Control Organisation (CDSCO) has approved an additional indication for Trastuzumab Deruxtecan 100 mg/5 mL vial lyophilized powder for concentrate for solution for infusion, in combination with Pertuzumab as a first-line treatment for adult patients with unresectable or metastatic HER2-positive (IHC 3+ or ISH+) breast cancer. In India, HER2-positive breast […]
Article by: IMT News Desk